[ He Cures Cancer by secret ancient text of Ayurveda in India.]

Navin Duggad of Chhindwara, Madhya Pradesh has successfully treated over 9000 cancer cases of all types with Ayurveda.

This is an incredible story of a self-taught Ayurved in Chhindwara, Madhya Pradesh, a dusty town in the Bastar Region, about 3 hours by taxi from Nagpur Airport. His name is Shri Navin Duggad and until about 3 years ago, this remarkable man was a jeweller and diamond merchant by trade. By his own admission, he and his 4 brothers together are considered to be the largest diamond merchant in Central Madhya Pradesh.

Shri Duggad’s transformation to an Ayurved happened about 3 years ago when his 89-year-old mother was afflicted with cancer. Shri Duggad decided that rather than subject her to the harsh treatments associated with modern medicine, he would use Ayurveda to treat her and keep her comfortable.

It is said he pored over a Hindi translation of Charak Samhita, the ancient text of Ayurveda, and came up with a regimen of diet and ayurvedic preparations to eliminate his mother’s cancer. She is still alive today. And she has motivated her son to focus only on this new gift he had developed to help the poor that suffer from various types of cancer.

For the last 3 years, Shri Duggad has treated over 9000 cancer patients with an incredible success rate of cure and remission. He has assiduously kept records of each patient he has helped, with detailed lab reports and tumour scans to show that he has beaten cancer in the vast majority of people he has treated.

Shri Duggad does not charge a penny for his service or his proprietary drugs, nor does he accept any donation. He works from 11 AM to 11 PM every day, often working well past midnight so that no patient goes away unattended.

His treatment consists of small amounts of herbal concoctions and powders (no heavy metal based bhasma) that have to be consumed over 6 days along with a strict dietary regimen. In addition, the patient has to remain in a completely darkened room (without even a chink of light, TV, cell phone or computer) for periods ranging from 15 to 28 days, depending on the nature of cancer. And he achieves a cure / remission in a matter of weeks, or a month or two, regardless of the type of cancer.

Shri Duggad says that modern medicinal practices of chemotherapy and radiation therapy are not only costly but ravages the body of the patient, creating other complications. While tumors may shrink and life span may increase marginally, death is painful and inevitable with modern medicine. Whereas, he argues, his approach gets to the root cause of the cancer and eliminates it in a gentle way where the body is not harmed in any manner.

In fact, Shri Duggad commented that the poor are lucky because their poverty eliminates the possibility of chemo or radiation therapy, leaving them no option but to seek out alternative therapies like what he practices. But he quickly added that he can also treat people who have undergone a great deal of chemo and radiation therapy and still save them very rapidly.

Shri Duggad is a deeply religious man. He is a Jain by faith and prays fervently each day in front of various pictures of Lord Mahaveera and the Theerthankaras before he starts his practice. He epitomizes the mysticism and inexplicability of India. And the adage "service before self".

I am a co-founder of a life sciences company focused on drug discovery. Being a person of modern science, I am normally prone to skepticism and disbelief about traditional practices. However, I have now personally met many patients under treatment as well as those who have fully recovered from cancers as diverse as prostate, liver, breast, stomach, salivary gland, eyes, throat and leukaemia. I have perused many lab reports associated with these cases and have seen irrefutable proof that Shri Duggad makes a difference. Needless to say, I am shaken and now a believer that modern science may not have all the answers . . and there is a place for alternative therapies.

- Rajan R. Srinivasan, Bangalore.

Points to Note:

Closest Airport – Nagpur.

Travel Time from Nagpur to Chhindwara by car – 3 hours.

New Patient Interview Date - ONLY FRIDAYS.

What lab reports to take – CBC, LFT, KFT, Thyroid, Lipid Profile.

System of appointment – First come, first served. Be prepared to wait for 3 to 6 hours.

Language - Shri Duggad speaks ONLY HINDI. Be prepared to take a translator if you don’t speak Hindi.

Buy all ayurvedic medicine raw materials that Shri Duggad suggests at the shop next to his facility.

Food - Carry water and light snacks – food service non-existent next to Shri Duggad’s facility.

Accommodations - for overnight stay, very poor. Recommend travel back to Nagpur.

Taxi Service suggested – Shri Jitendra - +91-94229-95598. Knows the place and can take you directly without any need to give directions. Charges Rs 3300 for round trip and 12 hours.

Please go to http://www.youtube.com/ and key in "Navin Duggad Chhindwada" and you can see and hear this amazing person talk about his unique practice.

http://www.webspawner.com/users/ravindra/

[Futuristic cancer treatment.]

John Grisham book turns spotlight on futuristic cancer treatment. (Reuters) By Amrutha Penumadi-

A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer's disease.

"The Tumor" is a fictional account of a 35-year-old man with brain cancer who, a decade into the future, is treated with focused ultrasound - a real-life technology that is currently being researched as a potential cure for more than 50 diseases.

Focused ultrasound uses soundwaves to destroy damaged tissue deep within the body, doing away with the need for incisions or radiation therapy. It has been approved in the United States as a treatment for several conditions, including prostate cancer.

As a treatment for brain and other cancers, it remains a futuristic concept. Research is at an early stage and, with clinical data in short supply, U.S. insurers have so far been reluctant to provide coverage.

But the book, which Grisham has released free of charge, could help developers to make a case for funding needed to take this niche technology into the mainstream, said several company executives and physicians interviewed by Reuters.

"Having a world-famous author talk about it can only help raise awareness," said Mark Carol, chief executive of Charlotte, North Carolina-based SonaCare Medical LLC.

SonaCare has two focused ultrasound devices on the market, one to treat diseased cells in soft tissue and another to ablate prostate tissue.

Men using SonaCare's device as a treatment for prostate cancer had a 9-in-10 chance that an MRI scan would show no sign of a tumor after 12 months, according to a study published in The Lancet Oncology in 2012. (http://bit.ly/1ppfkHR)

InSightec Ltd, an Israeli company backed by General Electric Co's GE Healthcare unit and York Capital Management, has approval for different uses: the treatment of bone metastases and uterine fibroids, benign growths in the walls of the uterus.

Maurice Ferré, InSightec's chief executive, said enquiries from patients about the company's devices for the brain had increased "by a factor of a hundred" since the book's release.

'LACK OF AWARENESS'

Grisham is on the board of the Focused Ultrasound Foundation, a non-profit organization. He describes "The Tumor" as "the most important book I've ever written."

The author of legal thrillers "The Firm" and "The Pelican Brief" says he was neither paid to write the book nor stands to gain financially.

In an emailed response to questions, he said "a lack of awareness about focused ultrasound is a major impediment to development of widespread use of this promising technology."

For Sherman Oaks, California-based BrainSonix Corp, which is conducting early-stage research on brain mapping, the book has led to a spike in enquiries from scientists and investors, said Chief Executive Alexander Bystritsky.

Other companies, such as Ann Arbor, Michigan-based HistoSonics Inc and France-based, Nasdaq-listed EDAP TMS SA, say the main benefit of the book will be to spread word among patients.

To date, successes such as this month's first prostate ablation treatment using technology developed by EDAP, have not translated into any prolonged bump in stock prices.

That's partly because focused ultrasound has been used only on small tumors that were diagnosed early and are easily visible on an imaging device, said Ashutosh Tewari, chairman of urology at Mount Sinai Health System, a New York City hospital network.

"I don't think this will become standard of care any time soon," said Tewari.

Treatment is more expensive than lasers and other thermal devices in everyday use. Big U.S. insurance companies have paid out on a case-by-case basis, unwilling to provide widespread coverage for what is a relatively untested technology.

Thomas Andreae, marketing director of magnetic resonance therapy at Philips Healthcare, said demand for the company's focused ultrasound devices was strongest in countries where a reimbursement structure was in place.

The company, part of Dutch conglomerate Philips, sells devices for the treatment of uterine fibroid outside the United States.

Ultimately, the potential for focused ultrasound could expand beyond surgical oncology to the treatment of Alzheimer's and other neurodegenerative diseases, said Kevyan Farahani, program director at the National Cancer Institute's imaging guided intervention branch.

The technology's potential to cut through a protective layer known as the blood-brain barrier would make it capable of delivering drugs straight to the brain, tackling a crucial issue in treating such diseases.

.